Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

2013 San Antonio Breast Cancer Symposium (SABCS) /
Male breast cancer: Opportunities for increased research funding and clinical trial access

9th - 11th Dec 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 19.12.13
Views: 2901

Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA

Dr Bogler talks to ecancertv at SABCS 2013 about male breast cancer.

It is estimated that 1% of breast cancer occurs in men: the American Cancer Society estimates 2,240 male breast cancer cases vs 234,580 female cases in 2013 in the US.

However, the male disease remains understudied and access to clinical trials for men is lags behind, as will be shown by analysis of grants, papers and trials.

Dr Bogler makes the case that by including research on male breast cancer alongside the female disease, and providing direct targeted funds, there is the opportunity to fill important gaps in knowledge. Furthermore, raising awareness and improving trial eligibility has the important potential to improve the outcome for men with breast cancer.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation